Mark Mercy is a creative leader with extensive experience in biopharmaceutical customer engagement and operations. They recently served as a Contract Operations lead at Genentech, where they won the Operational Impact Award in 2022 for redesigning a $3.5B specialty pharmacy access program. Mark has a proven track record of driving significant business growth, exemplified by their role as a Therapeutic Area Manager, where they grew the New England business to $100M in annual revenue. Mark's educational background includes an Executive MBA from Quantic School of Business and Technology, expected to be completed in 2025, and a Bachelor of Science in Business Administration from Champlain College.
This person is not in any teams
This person is not in any offices